Garner William

Garner J.
William was the founder of Kintara Therapeutics, Inc. founded in 2009, serving as Independent Director from 2015 to 2016.
Founder of Vaneltix Pharma, Inc. founded in 1997, holding the titles of President, Chief Executive Officer & Director from 1997 to 2010.
Founder of Inverseon, Inc. founded in 2004, acting as Chairman & Chief Executive Officer from 2009 to 2012.
Founder of EGB Ventures LLC founded in 2015, serving as Managing Director since 2015.
Founder of Del Mar Pharmaceuticals (BC) Ltd. founded in 2010, serving as Director from 2010 to 2016.
Founder of Invion Ltd. founded in 2012, holding the titles of Chief Executive Officer & Managing Director from 2012 to 2013.
Founder of Race Oncology Ltd. founded in 2016, acting as Non-Executive Director in 2020.
Founder of ISLA Pharmaceuticals founded in 2017, serving as Non-Executive Director since 2020.
Founder of Tryp Therapeutics, Inc. founded in 2019, acting as Executive Director from 2020 to 2022.
Founder of GeneTether, Inc. founded in 2018, serving as Director since 2018.
Founder of Rize Oncology, Inc. founded in 2018, holding the title of Executive Director from 2018 to 2025.
Dr. William is also the founder of Igxbio, Inc.,Urigen N.A, Inc.,Update Pharma, Inc...
Dr. William currently serves as Director at Innovation Angel Foundation, Inc. Former positions include Chief Executive Officer at Valentis, Inc., Chairman at InMed Pharmaceuticals, Inc. from 2016 to 2022, Head-Medical Affairs at Roche Holding AG, Associate at Paramount Capital, Inc., and Principal at Roche Laboratories, Inc. Education includes a doctorate from New York Medical College and graduate studies at Harvard T.H.
Chan School of Public Health.